# Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca

> **NCT01074814** · EARLY_PHASE1 · COMPLETED · sponsor: **Translational Drug Development** · enrollment: 28 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Approved therapy will be assigned based on molecular profile and RPMA results

## Key facts

- **NCT ID:** NCT01074814
- **Lead sponsor:** Translational Drug Development
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01074814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01074814, "Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01074814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*